Stabilized insulin-like growth factor polypeptides

Details for Australian Patent Application No. 2007255419 (hide)

Owner Novartis AG

Inventors Glass, David; Rajuseetharaman, Gopinath; Fornaro, Mara

Agent Blake Dawson Patent Attorneys

Pub. Number AU-A-2007255419

PCT Pub. Number WO2007/141309

Priority 60/812,349 09.06.06 US; 60/897,187 24.01.07 US; 60/862,244 20.10.06 US

Filing date 6 June 2007

Wipo publication date 13 December 2007

International Classifications

A61K 38/30 (2006.01) Medicinal preparations containing peptides - Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2

C07K 14/43 (2006.01) Peptides having more than 20 amino acids

C07K 14/65 (2006.01) Peptides having more than 20 amino acids

Event Publications

11 December 2008 PCT application entered the National Phase

  PCT publication WO2007/141309 Priority application(s): WO2007/141309

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007255428-Bracket with a pad

2007255418-Process for preparing spray dried formulations of TMC125